Astrana Health, Inc.
ASTH
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $1.9B
$38.47
▲ +1.69%
P/E
46.48
Mkt Cap
$1.9B
52-Wk Range
$18.08–$51.60
52-Week Range
$18.08 - $51.60
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 30.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary population health management and healthcare delivery platform
- Extensive integrated physician network spanning primary care, specialists, and hospitalists
- Value-based care model alignment with industry trends and regulatory incentives
- Multi-payer diversification across Medicare, Medicaid, and private insurance
Bear Case
2 risks
- Average volatility.
- Growth premium of 1.5x vs Healthcare Facilities peers. Elevated but may be justified by growth trajectory.
Growth
Stable outlook
Expansion of value-based care adoption across U.S. healthcare system
Value
Growth premium of 1.5x vs Healthcare Facilities peers. Elevated but may be justified by growth trajectory.
Momentum
Stable
+0.2% over 3m
Quality
Thin
Emerging growth company (59% revenue growth). Early stage with higher risk.
Dividend
None
No dividend
Smart-money signal
Who's buying ASTH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.40 vs $0.34 consensus (+19.1% surprise). Revenue of $972.5M vs $985.6M expected (-1.3%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+19.1%
Revenue trend · last 8Q
—
—
+53%
+35%
+100%
+43%
+56%
+49%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$478.7M
$665.2M
$620.4M
$654.8M
$956.0M
$950.5M
$965.1M
$972.5M
Margins · last 8Q
Gross
0.0%
Operating
3.5%
Profit
2.0%
Wall Street consensus
6 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Barclays · Aug 7, 2026
vs Industry
How ASTH stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related